...
首页> 外文期刊>The Journal of investigative dermatology. >Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses.
【24h】

Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses.

机译:人CD4 + T淋巴细胞对树突状细胞具有明显的调节功能,并具有镍特异性Th1免疫应答。

获取原文
获取原文并翻译 | 示例
           

摘要

The contribution of T helper (Th) and T cytotoxic (Tc) type 1 lymphocytes in the expression of allergic contact dermatitis to haptens has been amply documented. Conversely, the existence of T cell-based regulatory mechanisms has been poorly investigated. Here, we examined the properties of a subset of nickel-specific CD4+ T cells displaying the cytokine profile (IL-10 , IL-5 , IFN-gamma+/-, IL-4+/-) of T regulatory cells 1 (Tr1) and with the potential to down-modulate immune responses to nickel. Tr1 clones were isolated from skin challenged with NiSO4 and peripheral blood of nickel-allergic patients, and from the blood of healthy individuals. Tr1 clones expressed CD25, CD28, CD30, CD26, and the IL-12 receptor beta2 chain upon activation, whereas the lymphocyte activation antigen-3 was present on 50% of the clones. Monocytes precultured with Tr1 cells in the presence of nickel, or treated with Tr1-derived supernatant, exhibited a markedly diminished capacity to stimulate nickel-specific Th1 responses. Tr1 supernatants also blocked the differentiation of dendritic cells (DC) from monocytes, as well as DC maturation and IL-12 production induced by lipopolysaccharide. As a consequence, the ability of DC to stimulate nickel-specific Th1 and Tc1 responses was greatly impaired. These inhibitory effects were completely prevented by IL-10, but not IL-5, neutralization. In aggregate, the results indicate that Tr1 cells can potently regulate the expression of Th1-mediated allergic diseases via release of IL-10.
机译:T辅助(Th)和T细胞毒性(Tc)1型淋巴细胞在变应性接触性皮炎对半抗原的表达中的贡献已得到充分证明。相反,对基于T细胞的调节机制的存在研究很少。在这里,我们检查了一部分镍特异性CD4 + T细胞的特性,这些细胞显示了T调节细胞1(Tr1)的细胞因子谱(IL-10,IL-5,IFN-γ+/-,IL-4 +/-)并有可能下调对镍的免疫反应。从NiSO4攻击的皮肤和镍过敏患者的外周血以及健康个体的血液中分离出Tr1克隆。 Tr1克隆在激活后表达CD25,CD28,CD30,CD26和IL-12受体beta2链,而淋巴细胞激活抗原3存在于50%的克隆中。在镍存在下用Tr1细胞预培养的单核细胞,或用Tr1衍生的上清液处理的单核细胞,其刺激镍特异性Th1反应的能力显着降低。 Tr1上清液还阻止树突状细胞(DC)从单核细胞分化,以及由脂多糖诱导的DC成熟和IL-12产生。结果,DC刺激镍特异性Th1和Tc1反应的能力大大受损。这些抑制作用完全被IL-10(但不是IL-5)中和所阻止。总体而言,结果表明Tr1细胞可以通过释放IL-10来有效调节Th1介导的过敏性疾病的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号